Hearing Loss Trial, Recruiting NCT05451628 Sponsor: Universitair Ziekenhuis Brussel Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT05451628
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who developed severe to profound hearing loss (in the ear or ears being implanted) after they had already learned to speak and hear
  • People who have had a CT scan of their cochlear implant electrode taken after surgery
  • People who had hearing tests — including tests for tones, speech in quiet, and speech in noisy conditions — completed before surgery
  • People who have been implanted with a MED-EL brand cochlear implant
  • People whose implant uses a Flex28, FlexSoft, or Standard electrode
  • People whose newly implanted ear is planned to be fitted with a SONNET 2, SONNET 3, or RONDO 3 sound processor
  • People whose sound processor on the newly implanted side has not yet been switched on for the first time
  • People whose implant electrode has been inserted deeply enough into the inner ear (at least 450 degrees of the spiral structure) (confirm with trial site)
  • People whose implant can use at least 10 active sound channels
  • People who are fluent in the language used at the trial centre
  • People who have signed and dated a consent form before any study procedures begin

Who may not be able to join:

  • People who do not meet all of the inclusion criteria listed above
  • People who use a combined Electric Acoustic Stimulation (EAS) sound processor, which combines a hearing aid and cochlear implant in one device
  • People implanted with older MED-EL implant models known as C40+, C40X, or C40C
  • People who have an Auditory Brainstem Implant (ABI) or a split electrode array, which are different types of hearing implant devices
  • People who, in the medical opinion of the trial investigator, may be at increased risk or may not be able to fully complete the study for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universitair Ziekenhuis Brussel
Registry
ClinicalTrials.gov
Start date
30 March 2022
Est. completion
1 January 2027

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Speech recognition test in quiet (S0): percentage correctly identified phonemes; Speech recognition test in quiet (S0): percentage correctly identified phonemes; Speech recognition test in quiet (S0): percentage correctly identified phonemes; Speech recognition test in quiet (S0): percentage correctly identified phonemes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov